Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Allen T Funkhouser, MC
EPIMRD Inc.
Principal Investigator - Craig LaForce, MD
North Carolina Clinical Research
Principal Investigator - David Miller, MD
Northeast Medical Research Associates, Inc.
Principal Investigator - Jeffrey Tillinghast, MD
The Clinical Research Center, LLC.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
North Dartmouth, Massachusetts, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Raleigh, North Carolina, United States
- Research Site
El Paso, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 May 2023
- Primary completion
- 21 Aug 2023
- Completion
- 21 Aug 2023
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 52
- Registry id
- NCT05850494
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.